Literature DB >> 29674480

Pharmacological treatment of COPD: the devil is always in the detail.

Dave Singh1, Peter J Barnes2, Robert Stockley3, Maria Victorina Lopez Valera4, Claus Vogelmeier5, Alvar Agusti6.   

Abstract

Mesh：

Year:  2018        PMID： 29674480     DOI： 10.1183/13993003.00263-2018

Source DB:  PubMed          Journal:  Eur Respir J        ISSN： 0903-1936            Impact factor:   16.671


× No keyword cloud information.
  4 in total

Review 1.  Animal Models Reflecting Chronic Obstructive Pulmonary Disease and Related Respiratory Disorders: Translating Pre-Clinical Data into Clinical Relevance.

Authors:  Lloyd Tanner; Andrew Bruce Single
Journal:  J Innate Immun       Date:  2019-09-17       Impact factor: 7.349

2.  When to use single-inhaler triple therapy in COPD: a practical approach for primary care health care professionals.

Authors:  S Gaduzo; V McGovern; J Roberts; J E Scullion; D Singh
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2019-02-13

3.  The TRIFLOW study: a randomised, cross-over study evaluating the effects of extrafine beclometasone/formoterol/glycopyrronium on gas trapping in COPD.

Authors:  James Dean; Catalina Panainte; Naimat Khan; Dave Singh
Journal:  Respir Res       Date:  2020-12-09

4.  New Perspectives on Chronic Obstructive Pulmonary Disease.

Authors:  Bartolome R Celli; Dave Singh; Claus Vogelmeier; Alvar Agusti
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2022-09-06
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.